RAPT Therapeutics
RAPT
RAPT was delisted on the 2nd of March, 2026.
95 hedge funds and large institutions have $626M invested in RAPT Therapeutics in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 42 increasing their positions, 15 reducing their positions, and 17 closing their positions.
90,075% more call options, than puts
Call options by funds: $14.4M | Put options by funds: $16K
180% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 15
12% more first-time investments, than exits
New positions opened: 19 | Existing positions closed: 17
0.83% less ownership
Funds ownership: 12.63% → 11.8% (-0.83%)
3% less funds holding
Funds holding: 98 → 95 (-3)
9% less capital invested
Capital invested by funds: $691M → $626M (-$64.7M)
33% less funds holding in top 10
Funds holding in top 10: 9 → 6 (-3)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
+$26.1M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$22.4M |
| 3 |
State Street
Boston,
Massachusetts
|
+$13.3M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$5.7M |
| 5 |
Walleye Capital
New York
|
+$5.69M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Woodline Partners
San Francisco,
California
|
-$18.9M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.5M |
| 3 |
Invesco
Atlanta,
Georgia
|
-$3.73M |
| 4 |
BlackRock
New York
|
-$3.18M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$2.71M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
101
UBS AM
Chicago,
Illinois
| – | -$288K | -1,498 | Closed |
|
102
VOYA Investment Management
Atlanta,
Georgia
| – | -$239K | -1,241 | Closed |
|
103
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
| – | -$226K | -1,177 | Closed |
|
104
Franklin Resources
San Mateo,
California
| – | -$209K | -1,084 | Closed |
|
105
Ensign Peak Advisors
Salt Lake City,
Utah
| – | -$162K | -843 | Closed |
|
106
SG Americas Securities
New York
| – | -$153K | -794 | Closed |
|
107
Wells Fargo
San Francisco,
California
| – | -$19K | -96 | Closed |
|
|
ACM
108
Aquatic Capital Management
Chicago,
Illinois
| – | -$12K | -63 | Closed |
|
|
HNWAG
109
High Net Worth Advisory Group
Naples,
Florida
| – | -$12K | -63 | Closed |
|
110
Allspring Global Investments
Charlotte,
North Carolina
| – | -$1K | -7 | Closed |
|
111
Nisa Investment Advisors
St. Louis,
Missouri
| – | -$160 | -1 | -33% |
|
RAPT Hedge Fund Activity: Q4 2022 in Review
95 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in RAPT Therapeutics (RAPT) for Q4 2022, worth a combined $626M — down 9.4% from $691M a quarter earlier.
Buyers outnumbered sellers: 19 funds opened new RAPT positions and 17 closed out — a net gain of 2 holders — while 42 added to existing stakes and 15 trimmed.
The largest buyer was Deep Track Capital, opening a new position worth an estimated $26.1M. The largest seller was Woodline Partners, cutting an estimated $18.9M.
- 95 institutional investors held RAPT Therapeutics (RAPT) as of Q4 2022, down from 98 in Q3 2022.
- Funds reported $626M of RAPT Therapeutics stock for Q4 2022, down 9.4% quarter-over-quarter.
- 19 funds opened new RAPT Therapeutics positions in Q4 2022 and 17 closed out, a net change of +2 holders.
- The largest RAPT Therapeutics buyer in Q4 2022 was Deep Track Capital, an estimated $26.1M added.
- The largest RAPT Therapeutics seller in Q4 2022 was Woodline Partners, an estimated $18.9M sold.
Based on aggregated 13F filings for Q4 2022.